Frankfurt am Main, September 2021. ACXIT Capital Partners acted as the exclusive M&A and financial advisor to the shareholders on the trade sale of Römergarten Senioren-Residenzen GmbH, a high-quality operator of elderly care facilities, to Domidep a portfolio company of the global infrastructure investment manager I Squared Capital.
Continue ReadingFrankfurt am Main, September 2021. ACXIT Capital Partners acted as the exclusive M&A and financial advisor to the shareholders on the sale of a 82.5% stake in Artemed Pflegezentren (in future branded ArteCare) to Perpetua Holding.
Continue ReadingFrankfurt am Main, 09 July 2021: ACXIT Capital Partners advised the majority shareholder of Protagen Protein Services on the merger with GeneWerk – a portfolio company of Ampersand Capital Partners.
Continue ReadingFrankfurt am Main, 24 July 2020. Meyer Burger Technology Ltd (SIX Swiss Exchange: MBTN) has announced on 22 July 2020 that 98.9% of the subscription rights have been exercised until the end of the subscription period on 22 July 2020, 12:00 CEST. In total, 1,272,465,688 new registered shares were offered to existing shareholders at a subscription price of CHF 0.09 per share. The 13,718,276 new registered shares to be issued, for which the subscription rights have not been exercised, will be sold on the market. The rights issue will thus generate gross proceeds of around CHF 115 Million.
Continue ReadingFrankfurt am Main, 17 July 2020. Zur Rose Group AG (the “Company” or “Zur Rose Group”) successfully completed the capital increase that was resolved yesterday. A total of 740,823 new shares were sold in an international private placement to institutional investors at a placement price of CHF 287.00 per new share (the “Placement Price”).
Continue ReadingFrankfurt am Main, 17 July 2020.
From diagnosis to delivery
– Telemedicine pioneer TeleClinic offering reimbursable consultation services compliant with German national health insurance scheme
– TeleClinic continuously expanding its time to market lead in the post-COVID-19 time
– Telemedicine to form an important element in Zur Rose healthcare ecosystem, serving as additional entry point for digital customer journey
– Doctors are given the opportunity to offer their expertise more flexible and independent of location
– Both companies’ core businesses are further strengthened through highly complementary competencies with regard to the electronic prescription (eRx)
Frankfurt am Main, 08 July 2020. ACXIT Capital Partners, a leading independent European corporate finance and financial advisory firm, is pleased to announce the addition of senior banker Lars T. Rückert to its financial sponsor practice. He is one of the bespoken industry experts in this field with profound understanding of corporate finance, M&A and capital markets as well as special experience in portfolio company management in the consumer/retail and e-commerce sector.
Continue ReadingOberhausen, 01 July 2020. Attorney Axel Schwentker sells the business operations of Fashion FC Club GmbH to Schulz Fashion GmbH.
Continue ReadingFrankfurt, 30 March 2020. Zur Rose Group AG (the “Company” or “Zur Rose”), via its subsidiary Zur Rose Finance B.V. (the “Issuer”), successfully completed the placement of senior unsecured bonds due 2025 (the “Bonds”), guaranteed by the Company and convertible into registered shares of the Company (the “Shares”).
Continue ReadingMunich/Frankfurt, 17. March 2020 ACXIT Recovery Management empfiehlt eine befristete Verlängerung des Insolvenzgeldzeitraums von drei Monaten auf sechs Monate durch die Bundesagentur für Arbeit, um Betriebsfortführungen während der Corona-Krise zu erleichtern.
Continue Reading